We have a variety of weight loss programs that start as low as $199 for our a-la-carte plan, up to $599 for our two signature programs, RM3 and GLP Elite
By application, the obesity segment is expected to grow significantly in the upcoming years
These numbers include dosing errors, contamination events, and allergic reactions to inactive ingredients not present in brand-name formulations
In the diabetes trial published in The Lancet in June 2026, retatrutide as a first drug drove blood sugar to near-normal levels in early type 2 diabetes while taking off 15.3 percent of body weight
Long-term studies highlight tirzepatides lasting impact
On December 9, 2025 , the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025 (H.R